Evolve Biosystems is a biotechnology company established in 2011, with a mission to enhance gut health through advanced, microbiome-based solutions. Its slogan, "Empowering Gut Health with Advanced, Microbiome-Based Solutions for All Stages of Life," encapsulates the company's dedication to creating products for various life stages and animal species. Their innovative platform addresses gut dysbiosis, fostering a healthy gut microbiome in newborn infants through consumer-directed home use products and specialized hospital-based neonatal ICU products.
Having attracted a $55.00M Series D investment in February 2021, Evolve Biosystems has garnered support from notable investors Cargill and Manna Tree. The company operates within the biotechnology, health care, and medical devices industries, signaling its potential impact in diverse sectors.
